Literature DB >> 18716875

Bridge treatments of hepatocellular carcinoma in cirrhotic patients submitted to liver transplantation.

Maurizio Pompili, Giampiero Francica, Gian Ludovico Rapaccini.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18716875     DOI： 10.1007/s10620-008-0435-3

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  7 in total

1.  Management of hepatocellular carcinoma.

Authors:  Jordi Bruix; Morris Sherman
Journal:  Hepatology       Date:  2005-11       Impact factor: 17.425

2.  Response to preoperative chemoembolization correlates with outcome after liver transplantation in patients with hepatocellular carcinoma.

Authors:  Gunda Millonig; Ivo W Graziadei; Martin C Freund; Werner Jaschke; Sylvia Stadlmann; Ruth Ladurner; Raimund Margreiter; Wolfgang Vogel
Journal:  Liver Transpl       Date:  2007-02       Impact factor: 5.799

3.  Percutaneous radiofrequency ablation of hepatocellular carcinoma as a bridge to liver transplantation.

Authors:  David S K Lu; Nam C Yu; Steven S Raman; Charles Lassman; Myron J Tong; Carolyn Britten; Francisco Durazo; Sammy Saab; Steven Han; Richard Finn; Jonathan R Hiatt; Ronald W Busuttil
Journal:  Hepatology       Date:  2005-05       Impact factor: 17.425

4.  Impact of pretransplantation transarterial chemoembolization on survival and recurrence after liver transplantation for hepatocellular carcinoma.

Authors:  Thomas Decaens; Françoise Roudot-Thoraval; Solange Bresson-Hadni; Carole Meyer; Jean Gugenheim; Francois Durand; Pierre-Henri Bernard; Olivier Boillot; Karim Boudjema; Yvon Calmus; Jean Hardwigsen; Christian Ducerf; Georges Philippe Pageaux; Sebastien Dharancy; Olivier Chazouilleres; Daniel Dhumeaux; Daniel Cherqui; Christophe Duvoux
Journal:  Liver Transpl       Date:  2005-07       Impact factor: 5.799

5.  Percutaneous ablation procedures in cirrhotic patients with hepatocellular carcinoma submitted to liver transplantation: Assessment of efficacy at explant analysis and of safety for tumor recurrence.

Authors:  Maurizio Pompili; Vincenzo Giorgio Mirante; Gianfranco Rondinara; Luigi Rainero Fassati; Fabio Piscaglia; Salvatore Agnes; Marcello Covino; Matteo Ravaioli; Stefano Fagiuoli; Giovanni Gasbarrini; Gian Ludovico Rapaccini
Journal:  Liver Transpl       Date:  2005-09       Impact factor: 5.799

6.  Radiofrequency ablation of small hepatocellular carcinoma in cirrhotic patients awaiting liver transplantation: a prospective study.

Authors:  Vincenzo Mazzaferro; Carlo Battiston; Stefano Perrone; Andrea Pulvirenti; Enrico Regalia; Raffaele Romito; Dario Sarli; Marcello Schiavo; Francesco Garbagnati; Alfonso Marchianò; Carlo Spreafico; Tiziana Camerini; Luigi Mariani; Rosalba Miceli; Salvatore Andreola
Journal:  Ann Surg       Date:  2004-11       Impact factor: 12.969

7.  Efficacy of loco-regional ablation therapy of HCC in a population of liver transplanted patients.

Authors:  Filomena Morisco; Rosa Stigliano; Andrew Godfrey; Gioacchino Leandro; David Patch; Brian Davidson; Keith Rolles; Arjun Dhillon; Amar Paul Dhillon; Alberto Quaglia; Andrew Kenneth Burroughs
Journal:  Dig Dis Sci       Date:  2007-10-13       Impact factor: 3.199
  7 in total
  1 in total

1.  Hepatocellular carcinoma: consensus recommendations of the National Cancer Institute Clinical Trials Planning Meeting.

Authors:  Melanie B Thomas; Deborah Jaffe; Michael M Choti; Jacques Belghiti; Steven Curley; Yuman Fong; Gregory Gores; Robert Kerlan; Phillipe Merle; Bert O'Neil; Ronnie Poon; Lawrence Schwartz; Joel Tepper; Francis Yao; Daniel Haller; Margaret Mooney; Alan Venook
Journal:  J Clin Oncol       Date:  2010-08-02       Impact factor: 44.544
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.